Precision medicine requires large amounts of data.

Biobanking Science: Patient Attitudes to Precision Medicine Studies

Governments and research organizations around the world are conducting large long-term precision medicine projects to understand how genetic and lifestyle factors cause disease. Longitudinal...

Mustang Bio And FDA Complete Pre-IND Meeting For MB-102 (CD123 CAR-T)

Mustang Bio, Inc., a Fortress Biotech Company, headquartered in the greater New York City area, is a clinical‐stage biopharmaceutical company focused on the development...

CIRM Grants $3.99 Million to Poseida’s P-PSMA101 CAR-T for Prostate Cancer

Poseida Therapeutics Inc., headquartered in San Diego, spun-out of Transposagen Biopharmaceuticals in 2015. The company is translating best-in-class gene engineering technologies into lifesaving cell...

Avalon Consolidates Its CAR-T Enterprise By Forming Subsidiary Avactis Biosciences

Avalon GloboCare Corp. is a global intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high impact, transformative cell-based /technologies and...
Liquid nitrogen free sperm biobanking

Biobanking Science: Biobank Sperm Without Liquid Nitrogen

With gene editing technology such as CRISPR, it is becoming quicker and easier to generate disease models for medical research. Researchers around the world...

Asterias Expands The Indication Exploration Scope For AST-OPC1 Cell Therapy

Asterias Biotherapeutics, Inc. is a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated with demyelination and cellular immunotherapies to treat...

FDA Grants Nohla Therapeutics’ Cell Therapy Dilanubicel Orphan Drug Designation for HSCT

Nohla Therapeutics, headquartered in Seattle, is a leading developer of “off-the shelf” cell therapies for patients with cancer and other diseases. Nohla’s proprietary notch...

Biobanking Consent: Informing Human Subjects of the Possibilities

As researchers, we are familiar with why we have the need for biobanking regulations due to the story of Henrietta Lacks. HeLa cells survived...

Cell Therapy – New Method To Reprogram T-cells Without Viral Vectors Developed At UCSF

  A new method has been developed, primarily by University of California San Francisco (UCSF) researcher Theo Roth of Alex Marson’s laboratory, to introduce gene...
HIV-1 stable in biobanked plasma samples.

Biobanking Science: HIV RNA Stable at -80°C in Biobanks

Biobanks facilitate research by collecting, storing and sharing samples. One of the major concerns that biobanks face is how to best maintain sample quality...

ARMADA, The Antibiotic Resistance Monitoring, Analysis And Diagnostics Alliance Biobank

ARMADA, is the Antibiotic Resistance Monitoring, Analysis and Diagnostics Alliance. It will be a publicly supported Global Biobank that will, for the first time,...

BC Platforms And Tieto Partner To Advance Precision Medicine For Nordic Healthcare Providers

BC Platforms, founded in 1997 from an MIT Whitehead project spinoff, is in the business of powerful genomic data management and analysis solutions. The...

Biotime Has Licensed One Of Its Pluripotent Cell Lines To GoLiver

BioTime Inc. is a clinical-stage biotechnology company, headquartered in the San Francisco Bay Area, focused on degenerative diseases. Its clinical programs are based on...